Piper Sandler raises Madrigal Pharmaceuticals stock price target to $540

Investing.comWednesday, October 15, 2025 at 11:13:06 AM
Piper Sandler raises Madrigal Pharmaceuticals stock price target to $540
Piper Sandler has raised its price target for Madrigal Pharmaceuticals to $540, reflecting strong confidence in the company's potential. This adjustment is significant as it highlights the optimism surrounding Madrigal's innovative treatments and their impact on the market. Investors and stakeholders should pay attention, as this could indicate a promising future for the company and its shareholders.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Piper Sandler raises Unity Bancorp price target to $61 on solid earnings
PositiveFinancial Markets
Piper Sandler has raised its price target for Unity Bancorp to $61 following the company's strong earnings report. This adjustment reflects confidence in Unity's financial performance and growth potential, which is significant for investors looking for promising opportunities in the banking sector.
Citi stock price target raised to $110 from $107 at Piper Sandler
PositiveFinancial Markets
Citi's stock price target has been raised to $110 from $107 by Piper Sandler, reflecting growing confidence in the bank's performance. This adjustment is significant as it indicates analysts' positive outlook on Citi's future, which could attract more investors and boost the stock's value.
Piper Sandler analyst notes Reddit user growth driven by Conversation feature
PositiveFinancial Markets
Piper Sandler's latest analysis highlights a significant increase in Reddit's user growth, attributed to the platform's new Conversation feature. This development is important as it not only enhances user engagement but also positions Reddit as a more competitive player in the social media landscape, potentially attracting more advertisers and investors.
Truist Securities initiates coverage on Madrigal Pharmaceuticals stock with Buy rating
PositiveFinancial Markets
Truist Securities has started coverage on Madrigal Pharmaceuticals, giving it a 'Buy' rating. This is significant as it reflects confidence in Madrigal's potential for growth and success in the pharmaceutical market, particularly with its innovative treatments. Investors may see this as a positive signal for future performance.
Piper Sandler upgrades NBT Bancorp stock rating to Overweight on valuation
PositiveFinancial Markets
Piper Sandler has upgraded NBT Bancorp's stock rating to 'Overweight', indicating a positive outlook based on the company's valuation. This upgrade is significant as it reflects confidence in NBT Bancorp's financial health and growth potential, which could attract more investors and positively influence the stock price.
Piper Sandler initiates Netskope stock with Overweight rating on growth potential
PositiveFinancial Markets
Piper Sandler has given Netskope an Overweight rating, highlighting the company's significant growth potential in the cybersecurity sector. This endorsement is important as it reflects confidence in Netskope's ability to capitalize on increasing demand for cloud security solutions, which could lead to a rise in stock value and attract more investors.
Piper Sandler initiates WaterBridge Infrastructure stock coverage with Neutral rating
NeutralFinancial Markets
Piper Sandler has started coverage of WaterBridge Infrastructure with a neutral rating, indicating a cautious approach to the company's stock. This matters because it reflects the investment firm's assessment of the company's potential in the market, which could influence investor decisions and market trends.
CommVault stock rating upgraded by Piper Sandler on Gen-Z positioning
PositiveFinancial Markets
CommVault's stock has received a significant upgrade from Piper Sandler, highlighting the company's strategic positioning to appeal to Gen-Z consumers. This upgrade is important as it reflects confidence in CommVault's ability to innovate and adapt to the changing market dynamics, particularly with younger demographics who are increasingly influential in technology adoption.
Latest from Financial Markets
Bank of America and BNY sued over financial ties to Jeffrey Epstein
NegativeFinancial Markets
A lawsuit has been filed against Bank of America and BNY, alleging that they financially benefited from their ties to Jeffrey Epstein's sex-trafficking operation. This case highlights the ongoing scrutiny of financial institutions and their involvement with controversial figures, raising questions about accountability and ethical practices in the banking sector.
Financial Services Roundup: Market Talk
NeutralFinancial Markets
In the latest Financial Services Roundup, insights are shared on Bank of America and the state of American car loans, providing a snapshot of current market trends. This information is crucial for investors and consumers alike, as it highlights the financial landscape and potential opportunities or challenges in the market.
Stifel initiates Revolution stock with Buy rating, $85 price target
PositiveFinancial Markets
Stifel has initiated coverage of Revolution stock with a Buy rating and set a price target of $85. This is significant as it indicates strong confidence in the company's future performance, potentially attracting more investors and boosting the stock's value. Such endorsements can lead to increased market interest and may positively impact Revolution's growth trajectory.
Stifel initiates coverage on Erasca stock with Buy rating, $4 price target
PositiveFinancial Markets
Stifel has begun coverage on Erasca stock, assigning it a 'Buy' rating with a price target of $4. This is significant as it reflects confidence in Erasca's potential for growth and could attract more investors to the company, boosting its market presence.
Stifel initiates coverage on Cogent stock with Hold rating, $16 price target
NeutralFinancial Markets
Stifel has begun coverage on Cogent stock, assigning it a Hold rating with a price target of $16. This move indicates a cautious approach towards the stock, suggesting that while it may not be a strong buy, it is also not expected to decline significantly. Investors should pay attention to this rating as it reflects Stifel's analysis of the company's potential performance in the market.
Freedom Capital Markets initiates Toast stock with Buy rating, $45 target
PositiveFinancial Markets
Freedom Capital Markets has initiated coverage of Toast stock with a Buy rating and a target price of $45. This is significant as it reflects confidence in Toast's growth potential and could attract more investors to the company, potentially boosting its stock price.